On the basis of our preclinical data demonstrating that phosphodiesterase-5 ( PDE5 ) inhibition can modulate these cell populations , we evaluated whether the PDE5 inhibitor tadalafil can revert tumor-induced immunosuppression and promote tumor immunity in patients with HNSCC .